Editor´s Pick

      Editor´s Pick

      European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy® for the Treatment of HIV in Pediatric Populations

      FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has authorized a new low-dose tablet dosage form of...
      Admin -
      Editor´s Pick

      Teva Announces Appointment of Richard Francis as President and CEO

      TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has...
      Admin -
      Editor´s Pick

      World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.

      GALWAY, Ireland--(BUSINESS WIRE)--Late in 2021, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for...
      Admin -
      Editor´s Pick

      PointClickCare Announces Real World Data Collaboration with Pfizer

      MISSISSAUGA, Ontario--(BUSINESS WIRE)--PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights, today announced a strategic collaboration with Pfizer...
      Admin -
      Editor´s Pick

      Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

      NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced early data from a Phase 2/3 clinical trial...
      Admin -
      Editor´s Pick

      Families of Those Living with a Severe Neurodevelopmental Disorder to Provide Perspective to FDA to Help Expedite New Treatments

      LOS ANGELES--(BUSINESS WIRE)--Families of loved ones living with Phelan-McDermid syndrome (PMS) will inform and educate the U.S. Food and Drug Administration (FDA) and other...
      Admin -
      123...8Page 1 of 8

      Recent Articles

      Clarify Health Recognized for Innovation in Patient Recruitment in Clinical Trials

      Industry News

      Dr. Ravi Karra Joins Advanced Clinical to Accelerate Global Growth and Deliver Innovative Oncology Trials

      Look Who’s On the Move!

      Nimble Therapeutics names Pete Gough as Chief Scientific Officer

      Look Who’s On the Move!

      Memgen Reports Results From Its First-In-Human Clinical Trial of MEM-288 in Solid Tumors Refractory to Checkpoint Inhibitors at SITC 2022

      Industry News

      Spirita Oncology, LLC Initiates a Phase 1 Clinical Trial of the Anti-Cancer Agent E6201 in Combination with Dabrafenib in Patients with Central Nervous System...

      Industry News

      Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis

      Industry News

      Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)

      Regulatory Affairs

      Ferring Receives U.S. FDA Approval for REBYOTA® (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic

      Regulatory Affairs

      insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer

      Look Who’s On the Move!

      Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer

      Look Who’s On the Move!

      ReCode Therapeutics Appoints Trisha Millican to Board of Directors

      Look Who’s On the Move!

      Amulet Capital Partners Acquires United Vein & Vascular Centers

      Industry News

      Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Administration for Reproxalap for the Treatment of Signs and Symptoms of Dry...

      Regulatory Affairs

      Gate Neurosciences Doses First Subject in a Translational EEG Biomarker Study of Apimostinel, a Rapid-Acting Treatment for Acute Depressive Disorders

      Industry News

      Microbiotica Announces Transition of Leadership

      Look Who’s On the Move!

      2021 © Copyright - TPMG

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.